• Login
    Browsing Health Protection Surveillance Centre (HPSC) by Title 
    •   Home
    • HSE
    • Health Protection Surveillance Centre (HPSC)
    • Browsing Health Protection Surveillance Centre (HPSC) by Title
    •   Home
    • HSE
    • Health Protection Surveillance Centre (HPSC)
    • Browsing Health Protection Surveillance Centre (HPSC) by Title
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Map of Submissions

    Home Page
    UlsterN
    4991
    UlsterS
    4991
    Connacht
    1672
    Munster
    54
    Leinster
    455

    Browse

    All of Lenus, The Irish Health RepositoryCommunitiesTitleAuthorsDate publishedSubjectsThis CollectionTitleAuthorsDate publishedSubjects

    My Account

    LoginRegister

    About

    About LenusDirectory of Open Access JournalsOpen Access Publishing GuideNational Health Library & Knowledge ServiceGuide to Publishers' PoliciesFAQsTerms and ConditionsVision StatementORCID Unique identifiers for ResearchersHSE position statement on Open AccessNational Open Research Forum (NORF)Zenodo (European Open Research repository)

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Browsing Health Protection Surveillance Centre (HPSC) by Title

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    xmlui.ArtifactBrowser.ConfigurableBrowse.view

    Sort by:

    Order:

    Results:

    Now showing items 29-48 of 1411

    • List view
    • Grid view
    • title
    • issue date
    • submit date
    • ascending
    • descending
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Thumbnail

        Biological threat agents

        National Disease Surveillance Centre (National Disease Surveillance Centre, 2002)
      • Thumbnail

        Biosafety guidance for diagnostic laboratories handling specimens from individuals with possible or confirmed infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [V1.1]

        Health Protection Surveillance Centre (Health Service Executive, 2021-01-06)
      • Thumbnail

        Biosafety guidance for diagnostic laboratories handling specimens from individuals with possible, probable or confirmed infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome Coronavirus or Avian Influenza A V3.0

        Health Protection Surveillance Centre (Health Service Executive, 2020-02-14)
      • Thumbnail

        Blood - borne viruses in the haemodialysis , CAPD and renal transplantation setting

        Health Service Executive, Health Protection Surveillance Centre (Health Protection Surveillance Centre, 2013)
      • Thumbnail

        Blood glucose monitoring: prevention of transmission of blood borne viruses

        Burns, Karen; Donlon, Sheila; Thornton, Lelia; Fitzpatrick, Fidelma; Health Protection Surveillance Centre (HPSC) (Health Protection Surveillance Centre (HPSC), 2011-01-01)
      • Thumbnail

        Blood-borne virus transmission in healthcare settings in Ireland: review of patient notification exercises 1997-2011

        Donohue, S; Thornton, L; Kelleher, K; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland. sinead.donohue1@hse.ie (Elsevier, 2012-07-02)
      • Thumbnail

        Blood-borne virus transmission in healthcare settings in Ireland: review of patient notification exercises 1997-2011.

        Donohue, S; Thornton, L; Kelleher, K; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland. (2012-01-21)
        A review of patient notification exercises (PNEs) carried out in Ireland between 1997 and 2011 to investigate potential exposure to blood-borne viruses (BBVs) in healthcare settings was undertaken to inform future policy and practice. A questionnaire was sent to key informants in the health services to identify all relevant PNEs. Structured interviews were conducted with key investigators, and available documentation was examined. Ten BBV-related PNEs were identified. Despite testing over 2000 patients, only one case of transmission was found. However, in-depth local investigations before undertaking the PNEs identified six cases of healthcare-associated transmission.
      • Thumbnail

        Blood-Borne viruses in the haemodialysis, CAPD and renal transplantation setting 2013

        Health Protection Surveillance Centre (HPSC); Health Service Executive (HSE) (Health Service Executive (HSE), 2013)
      • Thumbnail

        Burden of imported malaria in Ireland: recommendations for surveillance and prevention

        HPSC Vectorborne Disease Sub-Committee; HSE Health Protection Surveillance Centre (HPSC); HSE Health Protection Surveillance Centre (HPSC) (HSE Health Protection Surveillance Centre (HPSC), 2010-09)
      • Thumbnail

        Case definitions for notifiable diseases

        Health Protection Surveillance Centre (HPSC) (Health Protection Surveillance Centre (HPSC), 2012)
      • Thumbnail

        Case definitions for notifiable diseases

        Health Protection Surveillance Centre; Health Service Executive (Health Protection Surveillance Centre, 2012)
      • Thumbnail

        Case definitions for notifiable diseases, March 2012

        Health Service Executive (HSE); Health Protection Surveillance Centre (HPSC) (HSE, Health Protection Surveillance Centre (HPSC), 2012-03)
      • Thumbnail

        Case definitions for notifiable diseases: Infectious Diseases (Amendment) (No.3) Regulations 2003

        Health Service Executive (HSE) (2003)
      • Thumbnail

        Challenges of implementing national guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus colonization or infection in acute care hospitals in the Republic of Ireland.

        Fitzpatrick, Fidelma; Roche, Fiona; Cunney, Robert; Humphreys, Hilary; Health Protection Surveillance Centre, Dublin 1, Ireland. fidelma.fitzpatrick@hse.ie (2009-03)
        Of the 49 acute care hospitals in Ireland that responded to the survey questionnaire drafted by the Infection Control Subcommittee of the Health Protection Surveillance Centre's Strategy for the Control of Antimicrobial Resistance in Ireland, 43 reported barriers to the full implementation of national guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus infection; these barriers included poor infrastructure (42 hospitals), inadequate laboratory resources (40 hospitals), inadequate staffing (39 hospitals), and inadequate numbers of isolation rooms and beds (40 hospitals). Four of the hospitals did not have an educational program on hand hygiene, and only 17 had an antibiotic stewardship program.
      • Thumbnail

        Changes in Invasive Pneumococcal Disease Caused by Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project.

        Health Protection Surveillance Centre; Bennett, Julia C; Hetrich, Marissa K; Garcia Quesada, Maria; Sinkevitch, Jenna N; Deloria Knoll, Maria; Feikin, Daniel R; Zeger, Scott L; Kagucia, Eunice W; Cohen, Adam L; et al. (Health Service Executive, 2021-03-27)
        Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (PCVs) containing ST1 antigen. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project gathered ST1 IPD surveillance data from sites globally and aimed to estimate PCV10/13 impact on ST1 IPD incidence. We estimated ST1 IPD incidence rate ratios (IRRs) comparing the pre-PCV10/13 period to each post-PCV10/13 year by site using a Bayesian multi-level, mixed-effects Poisson regression and all-site IRRs using a linear mixed-effects regression (N = 45 sites). Following PCV10/13 introduction, the incidence rate (IR) of ST1 IPD declined among all ages. After six years of PCV10/13 use, the all-site IRR was 0.05 (95% credibility interval 0.04-0.06) for all ages, 0.05 (0.04-0.05) for <5 years of age, 0.08 (0.06-0.09) for 5-17 years, 0.06 (0.05-0.08) for 18-49 years, 0.06 (0.05-0.07) for 50-64 years, and 0.05 (0.04-0.06) for ≥65 years. PCV10/13 use in infant immunization programs was followed by a 95% reduction in ST1 IPD in all ages after approximately 6 years. Limited data availability from the highest ST1 disease burden countries using a 3+0 schedule constrains generalizability and data from these settings are needed.
      • Thumbnail

        Checklist for Residential Care Facilities on the Prevention, Detection and Control of Influenza-like illness and Influenza Outbreaks 2020/2021

        Health Protection Surveillance Centre (Health Service Executive, 2020-11-10)
      • Thumbnail

        Checklist to support a health care facility (HCF) using Powered Air Purifying Respirators (PAPRs) (formerly Appendix 5 of Infection Prevention and Control precautions for acute settings)

        Health Protection Surveillance Centre (Health Service Executive, 2020-12)
      • Thumbnail

        Checklist to support COVID-19 outbreak management in acute healthcare setting (formerly Appendix 4 of acute guidance document)

        Health Protection Surveillance Centre (Health Service Executive, 2020-12-22)
      • Thumbnail

        Checklist to support COVID-19 outbreak management in acute healthcare setting (formerly Appendix 4 of acute guidance document)

        Health Protection Surveillance Centre (Health Service Executive, 2020-12)
      • Thumbnail

        Chlamydia screening in Ireland: A pilot study of opportunistic screening for genital chlamydia trachomatic infection in Ireland (2007 - 2009): summary integrated report

        Health Protection Surveillance Centre, Chlamydia Screening Steering Group (Health Protection Surveillance Centre; Health Research Board, 2012)
        National Health Library & Knowledge Service | Health Service Executive | Dr Steevens' Hospital | Dublin 8 | Ireland
        lenus@hse.ie | Tel +353 (1) 6352558
        DSpace software copyright © 2002-2017  DuraSpace
        Contact Us | Disclaimer
        Open Repository is a service operated by 
        Atmire NV
         

        Export search results

        The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

        By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

        To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

        After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.